Share Name Share Symbol Market Type Share ISIN Share Description
Rbg Holdings Plc LSE:RBGP London Ordinary Share GB00BFM6WL52 ORD GBP0.002
  Price Change % Change Share Price Shares Traded Last Trade
  -0.50 -0.75% 66.00 181,986 09:50:45
Bid Price Offer Price High Price Low Price Open Price
65.00 67.00 66.50 66.00 66.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 19.94 7.65 7.56 8.7 53
Last Trade Time Trade Type Trade Size Trade Price Currency
17:10:47 O 30,000 66.00 GBX

Rbg (RBGP) Latest News

More Rbg News
Rbg Investors    Rbg Takeover Rumours

Rbg (RBGP) Discussions and Chat

Rbg Forums and Chat

Date Time Title Posts
20/10/202015:49Rosenblatt Group Plc291

Add a New Thread

Rbg (RBGP) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Rbg trades in real-time

Rbg (RBGP) Top Chat Posts

Rbg Daily Update: Rbg Holdings Plc is listed in the Support Services sector of the London Stock Exchange with ticker RBGP. The last closing price for Rbg was 66.50p.
Rbg Holdings Plc has a 4 week average price of 58.50p and a 12 week average price of 57.50p.
The 1 year high share price is 102.50p while the 1 year low share price is currently 50p.
There are currently 80,092,106 shares in issue and the average daily traded volume is 194,503 shares. The market capitalisation of Rbg Holdings Plc is £52,860,789.96.
scubadiverr: Crazy isn't it that RBGP trade at less than half the PE of Manolete yet have exposure to a number of high yielding activities, which are all likely to show high growth, when Manolete appear a 1 trick pony those margins are soon to be eroded?
buying: ST of the investors Chronicle maintains his one pound price target
energeticbacker: Investor's Champion comments on RBGP's welcome boost on better news from its portfolio of companies. The shares trade at only 8.5x reported earnings per share for 2019, suggesting significant recovery potential.
scooper72: Sorry but what happened today. Did I miss some news. My HL account hasn't got any news under the share info. ...always knew I should be trading this a bit - this is about the 3rd time it has dropped back. Might just have to open a little spread bet to complement the IsA holding.
thirty fifty twenty: hello any got any interesting conspiracy theories as to why RBGP changed the time of their results presentation from 4pm to 11am on Wednesday. I found it a bit surprising it was changed with such short notice, and that the change came at 10pm on a Sunday!! mostly likely is a simple mess up (probably) by the meeting organiser you;d assume, but if it is a genuine change because of a change - they it must be a pretty important meeting that the CEO needs to attend at 4.30 to cause themselves the embarrassment of changing the times at 2 days notice, and on a Sunday thoughts welcome All IMHO, DYOR + BoL RBGP is in my top5 hldgs
jonwig: Incidentally, there's a presentation coming up (16/09; 4:30pm). Anyone can join:
buying: Although I think it's very optimistic to say the share price will double there is a growth story unfolding here. I've bought in and out over the years but think I will stay put for a while. There's a dividend while you wait
standish11: In early June, I suggested buying shares in RBG (RBGP:65p), a professional services group that owns law firm, Rosenblatt, a nascent litigation funding arm, and specialist finance boutique Convex Capital (Alpha Report: ‘Back a winning legal team’, 2 June 2020). A pre-close trading update released ahead of first half results on Wednesday, 16 September 2020 makes me even more convinced that there is potential to double your money over the next 12 months. Rosenblatt has enjoyed a good lockdown, winning a broad range of new instructions, including corporate transactions, employment advisory work and financial restructuring mandates. In fact, Rosenblatt’s first half revenue has soared 38 per cent to £11.2m. It’s high margin work, too, generating a 40 per cent cash profit margin. That’s because Rosenblatt’s team of 46 fee-earning legal eagles specialise in litigious/contentious work that enables the firm to bill clients by the hour and control the level of fees it charges. Dispute resolution-related work accounts for two thirds of the business whereas listed rivals have greater exposure to more commoditised general legal services work which has lower pricing and where fixed fee structures are common. The top 200 UK law firm has a strong pipeline of opportunities, hardly surprising given that the pandamic induced economic downturn is likely to lead to a boom in dispute resolution work and employment related law suits. I also note that RBG’s litigation finance arm expects to “execute four potentially significant commercial litigation financing transactions imminently” and has a growing pipeline of opportunities. Furthermore, the directors plan to sell a proportion of these investments as was the case in 2019. Selling down participation rights in contingent cases contributes to one-off revenues, and enables cash to be recycled into additional cases to diversifty the portfolio. Rosenblatt has an enviable track record of success in this area. Since taking on contingent work in 2011, the law firm has won 19 of the 22 cases that have concluded to date. Convex Capital, the specialist sell-side corporate finance boutique acquired by RBG in September 2019, has a strong pipeline of deals (around 30 with each one potentially worth £1m in fees), albeit the Covid-19 pandemic has resulted in transaction deferrals and it’s uncertain how many deals will conclude in the second half. However, as I noted five weeks ago, there is silver lining. That’s because £6.6m of the deferred consideration on the acquisition price represents a contingent earn-out to be settled in shares (minimum issue price of 140p), but only if Convex exceeds a cash profit of £6m for the 12 months to mid-September 2020. In other words, RBG’s exisiting shareholders will avoid dilution if Convex fails to hit its target, but still retain 100 per cent ownership of the business. That’s not a bad outcome at all. Trading on a price-to-book value of 1.3 times, historic price/earnings ratio of 8.5 and offering a trailing dividend yield of 4.6 per cent, the potential for Rosenblatt’s high earning legal eagles to continue to create value for shareholders is woefully undervalued. Buy. Above is by Simon Thompson.
beckaroo: At least the deferred consideration for Convex should will probably not all be paid.A deferred consideration, payable after one year, of GBP8.4 million. Of this GBP8.4 million, GBP1.8m million will be paid in cash, and GBP6.6 million will be satisfied by the issue of 4.7 million new Rosenblatt shares (the "Deferred Consideration Shares"), at a minimum price of 140 pence per share (a premium of 58.2% to the closing price on 13 September 2019) or, if higher, the market value of the shares at the time. The Deferred Consideration Shares will only be issued if Convex exceeds a threshold EBITDA of GBP6 million for the period from 16 September 2019 to 16 September 2020.
quepassa: 245 refers. the share price graph refers
Rbg share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201021 20:29:02